JAPAN-HEALTH-EBOLA-FUJIFILM-US-MERGER

Sales clerks wait for customers at their stall selling cosmetics made by Japan's Fujifilm in Tokyo on October 27, 2014. Fujifilm said it would buy a US vaccine maker as the Japanese firm increases its supply of an experimental Ebola drug to help stem the spread of the virus. The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details. AFP PHOTO / Yoshikazu TSUNO (Photo by YOSHIKAZU TSUNO / AFP) (Photo by YOSHIKAZU TSUNO/AFP via Getty Images)
Sales clerks wait for customers at their stall selling cosmetics made by Japan's Fujifilm in Tokyo on October 27, 2014. Fujifilm said it would buy a US vaccine maker as the Japanese firm increases its supply of an experimental Ebola drug to help stem the spread of the virus. The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details. AFP PHOTO / Yoshikazu TSUNO (Photo by YOSHIKAZU TSUNO / AFP) (Photo by YOSHIKAZU TSUNO/AFP via Getty Images)
JAPAN-HEALTH-EBOLA-FUJIFILM-US-MERGER
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
475,00 €
EUR

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales. Derechos editoriales plenos en Reino Unido, EE.UU., Irlanda, Italia, España y Canadá (excepto Québec). Si desea conocer los derechos editoriales restringidos en otro país, llame a su oficina local.
Crédito:
YOSHIKAZU TSUNO / Fotógrafo de plantilla
Editorial n.º:
457935594
Colección:
AFP
Fecha de creación:
27 de octubre de 2014
Fecha de subida:
Tipo de licencia:
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
AFP
Código de barras:
AFP
Nombre del objeto:
Hkg10112350
Tamaño máx. archivo:
2752 x 3858 px (23,30 x 32,66 cm) - 300 dpi - 3 MB